Pet-related infections

American Family Physician

Volumn 76, Issue 9, 2007, Pages 1314-1322

  Rabinowitz, Peter M ^a   Gordon, Zimra ^b   Odofin, Lynda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rippowam Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTICIN; ALBENDAZOLE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; FOLINIC ACID; GENTAMICIN; IVERMECTIN; MINOCYCLINE; NITAZOXANIDE; PENICILLIN G; PERMETHRIN; PRAZIQUANTEL; PREDNISONE; PYRIMETHAMINE; RABIES VACCINE; RIFAMPICIN; SPIRAMYCIN; STREPTOMYCIN; SULFADIAZINE; TINIDAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BACTERIAL INFECTION; BLOOD CULTURE; BRUCELLOSIS; CAMPYLOBACTER; CAT SCRATCH DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOSPORIDIOSIS; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE INFECTION; HIGH RISK POPULATION; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION RISK; LEPTOSPIROSIS; LEUKOCYTE; LEUKOCYTE COUNT; LYME DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONKEYPOX; MYCOSIS; NONHUMAN; ORNITHOSIS; PARASITOSIS; PET ANIMAL; POLYMERASE CHAIN REACTION; RABIES; REVIEW; SALMONELLOSIS; SCABIES; SEROLOGY; TINEA; TINEA CAPITIS; TINEA CORPORIS; TOXOCARA CANIS; TOXOCARIASIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TULAREMIA; UNITED STATES; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MENINGITIS; VISCERAL LARVA MIGRANS SYNDROME;

ANIMALS; ANIMALS, DOMESTIC; DISEASE VECTORS; HUMANS; ZOONOSES;

EID: 36248958161     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Stehr-Green JK, Schantz PM. The impact of zoonotic diseases transmitted by pets on human health and the economy. Vet Clin North Am Small Anim Pract 1987;17:1-15.
2. Wise JK, Heathcott BL, Shepherd AJ, for the AVMA. Results of the 2002 AVMA survey of US pet-owning households regarding use of veterinary services and expenditures. J Am Vet Med Assoc 2003;222:1524-5.
3. Grant S, Olsen CW. Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians. Emerg Infect Dis 1999;5:159-63.
4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-76.
5. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003;16:265-72.
6. Gilbert DN, Moellering RC Jr, Eliopoulos GM, Sande MA, eds. Table 13A: Treatment of parasitic infections. In: Sanford JP, ed. The Sanford Guide to Antimicrobial Therapy 2007. 37th ed. Sperryville, Va.: Antimicrobial Therapy, 2007:122-30.
7. Gilbert DN, Moellering RC Jr, Eliopoulos GM, Sande MA, eds. Table 1: Clinical approach to initial choice of antimicrobial therapy. In: Sanford JP, ed. The Sanford Guide to Antimicrobial Therapy 2007. 37th ed. Sperryville, Va.: Antimicrobial Therapy, 2007:4-58.
8. Blumer JL. Pharmacologic basis for the treatment of tinea capitis. Pediatr Infect Dis J 1999;18:191-9.
9. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997;3:213-21.
10. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al., for the Peru-United States Leptospirosis Consortium. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.
11. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
12. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000;283:2281-90.
13. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al., for the Working Group on Civilian Biodefense. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73.
14. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997;156 (2 pt 2):S1-25.
15. Mathisen GE. Of mites and men - lessons in scabies for the infectious diseases clinician. Clin Infect Dis 1998;27:646-8.
16. Jackson AC. Recovery from rabies. N Engl J Med 2005;352:2549-50.
17. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington C, et al., for the Toxoplasmosis Study Group. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 2005;192:564-71.
18. Schantz PM. Toxocara larva migrans now. Am J Trop Med Hyg 1989;41(3 suppl):21-34.
19. Chorazy ML, Richardson DJ. A survey of environmental contamination with ascarid ova, Wallingford, Connecticut. Vector Borne Zoonotic Dis 2005;5:33-9.
20. Chrieki M. Echinococcosis - an emerging parasite in the immigrant population. Am Fam Physician 2002;66:817-20.
21. Schantz PM. Progress in diagnosis, treatment and elimination of echinococcosis and cysticercosis. Parasitol Int 2006;55(suppl):S7-S13.
22. Centers for Disease Control and Prevention (CDC). Turtle-associated salmonellosis in humans - United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007;56:649-52.
23. Swanson SJ, Snider C, Braden CR, Boxrud D, Wunschmann A, Rudroff JA, et al. Multidrug-resistant Salmonella enterica serotype Typhimurium associated with pet rodents. N Engl J Med 2007;356:21-8.
24. Spach DH, Koehler JE. Bartonella-associated infections. Infect Dis Clin North Am 1998;12:137-55.
25. Barry M, Wisnewski AV, Matthias MA, Inouye SK, Vinetz JM. Suburban leptospirosis: atypical lymphocytosis and gamma-delta T cell response. Clin Infect Dis 2006;43:1304-7.
26. Manian FA. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 2003;36:e26-8.
27. Enoch DA, Karas JA, Slater JD, Emery MM, Kearns AM, Farrington M. MRSA carriage in a pet therapy dog. J Hosp Infect 2005;60:186-8.
28. Kimura R, Hayashi Y, Takeuchi T, Shimizu M, Iwata M, Tanahashi J, et al. Pasteurella multocida septicemia caused by close contact with a domestic cat: case report and literature review. J Infect Chemother 2004;10:250-2.
29. Smith KA, Bradley KK, Stobierski MG, Tengelsen LA, for the National Association of State Public Health Veterinarians Psittacosis Compendium Committee. Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds, 2005. J Am Vet Med Assoc 2005;226:532-9.
30. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C, for the Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33.
31. Lucero NE, Jacob NO, Ayala SM, Escobar GI, Tuccillo P, Jacques I. Unusual clinical presentation of brucellosis caused by Brucella canis. J Med Microbiol 2005;54(pt 5):505-8.
32. Streit M, Bohlen LM, Hunziker T, Zimmerli S, Tscharner GG, Nievergelt H, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006;16:79-83.
33. Gage KL, Dennis DT, Orloski KA, Ettestad P, Brown TL, Reynolds PJ, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis 2000;30:893-900.
34. Centers for Disease Control (CDC). Tularemia associated with domestic cats - Georgia, New Mexico. MMWR Morb Mortal Wkly Rep 1982;31:39-41.
35. Centers for Disease Control and Prevention (CDC). Update: interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. MMWR Morb Mortal Wkly Rep 2005;54:799-801.
36. Krebs JW, Long-Marin SC, Childs JE. Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract 1998;4:56-62.
37. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004;350:342-50.
38. Duncan AW, Correa MT, Levine JF, Breitschwerdt EB. The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis 2005;5:101-9.
39. Songsermn T, Amonsin A, Jam-on R, Sae-Heng N, Meemak N, Pariyothorn N, et al. Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 2006;12:681-3.
40. Allert C. Reducing risk of zoonotic parasitic diseases - a shared responsibility. Roundtable: veterinarians, physicians jointly responsible. J Am Vet Med Assoc 1995;207:403-4.
41. Wong SK, Feinstein LH, Heidmann P. Healthy pets, healthy people. J Am Vet Med Assoc 1999;215:335-8.
42. Centers for Disease Control and Prevention. Healthy pets healthy people. Accessed May 10, 2007, at http://www.cdc.gov/healthypets.
43. Centers for Disease Control and Prevention, U.S. Public Health Service, Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Atlanta, Ga.: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2002.
44. Medeiros I, Saconato H. Antibiotic prophylaxis for mammalian bites. Cochrane Database Syst Rev 2001;(2):CD001738.
45. Hemsworth S, Pizer B. Pet ownership in immunocompromised children - a review of the literature and survey of existing guidelines. Eur J Oncol Nurs 2006;10:117-27.
46. Kahn LH. Confronting zoonoses, linking human and veterinary medicine. Emerg Infect Dis 2006;12:556-61.